Log in to save to my catalogue

New Angiogenic Regulators Produced by TAMs: Perspective for Targeting Tumor Angiogenesis

New Angiogenic Regulators Produced by TAMs: Perspective for Targeting Tumor Angiogenesis

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8268686

New Angiogenic Regulators Produced by TAMs: Perspective for Targeting Tumor Angiogenesis

About this item

Full title

New Angiogenic Regulators Produced by TAMs: Perspective for Targeting Tumor Angiogenesis

Publisher

Basel: MDPI AG

Journal title

Cancers, 2021-06, Vol.13 (13), p.3253

Language

English

Formats

Publication information

Publisher

Basel: MDPI AG

More information

Scope and Contents

Contents

Angiogenesis is crucial to the supply of a growing tumor with nutrition and oxygen. Inhibition of angiogenesis is one of the main treatment strategies for colorectal, lung, breast, renal, and other solid cancers. However, currently applied drugs that target VEGF or receptor tyrosine kinases have limited efficiency, which raises a question concernin...

Alternative Titles

Full title

New Angiogenic Regulators Produced by TAMs: Perspective for Targeting Tumor Angiogenesis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8268686

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8268686

Other Identifiers

ISSN

2072-6694

E-ISSN

2072-6694

DOI

10.3390/cancers13133253

How to access this item